 |
|
Long-term All-Cause Mortality in Cancer Patients With Preexisting Diabetes MellitusA Systematic Review and Meta-analysis
Bethany B. Barone, ScM;
Hsin-Chieh Yeh, PhD;
Claire F. Snyder, PhD;
Kimberly S. Peairs, MD;
Kelly B. Stein, MD;
Rachel L. Derr, MD;
Antonio C. Wolff, MD;
Frederick L. Brancati, MD, MHS
JAMA. 2008;300(23):2754-2764.
Context Diabetes mellitus appears to be a risk factor for some cancers, but the effect of preexisting diabetes on all-cause mortality in newly diagnosed cancer patients is less clear.
Objective To perform a systematic review and meta-analysis comparing overall survival in cancer patients with and without preexisting diabetes.
Data Sources We searched MEDLINE and EMBASE through May 15, 2008, including references of qualifying articles.
Study Selection English-language, original investigations in humans with at least 3 months of follow-up were included. Titles, abstracts, and articles were reviewed by at least 2 independent readers. Of 7858 titles identified in our original search, 48 articles met our criteria.
Data Extraction One reviewer performed a full abstraction and other reviewers verified accuracy. We contacted authors and obtained additional information for 3 articles with insufficient reported data.
Results Studies reporting cumulative survival rates were summarized qualitatively. Studies reporting Cox proportional hazard ratios (HRs) or Poisson relative risks were combined in a meta-analysis. A random-effects model meta-analysis of 23 articles showed that diabetes was associated with an increased mortality HR of 1.41 (95% confidence interval [CI], 1.28-1.55) compared with normoglycemic individuals across all cancer types. Subgroup analyses by type of cancer showed increased risk for cancers of the endometrium (HR, 1.76; 95% CI, 1.34-2.31), breast (HR, 1.61; 95% CI, 1.46-1.78), and colorectum (HR, 1.32; 95% CI, 1.24-1.41).
Conclusions Patients diagnosed with cancer who have preexisting diabetes are at increased risk for long-term, all-cause mortality compared with those without diabetes.
Author Affiliations: Departments of Epidemiology (Ms Barone and Drs Yeh and Brancati) and Health Policy and Management (Dr Snyder), Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland; Division of General Internal Medicine (Drs Yeh, Snyder, Peairs, Stein, and Brancati), Division of Endocrinology and Metabolism (Dr Derr), and Division of Oncology (Drs Snyder and Wolff), Johns Hopkins Medical Institutes, Baltimore.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
RELATED LETTERS
Long-term Mortality in Cancer Patients With Preexisting Diabetes
and
JAMA. ;301():1541-1541.
FULL TEXT
Long-term Mortality in Cancer Patients With Preexisting Diabetes--Reply
, , and
JAMA. ;301():1541-1541.
FULL TEXT
Depression, Homocysteine Concentration, and Cardiovascular Events
and
JAMA. ;301():1541-1542.
FULL TEXT
Depression, Homocysteine Concentration, and Cardiovascular Events--Reply
JAMA. ;301():1542-1542.
FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Metformin, Cancer, Alphabet Soup, and the Role of Epidemiology in Etiologic Research
Duncan and Schmidt
Diabetes Care 2009;32:1748-1750.
FULL TEXT
Prevalence and Predictors of Breast and Cervical Cancer Screening Among Spanish Women With Diabetes
Jimenez-Garcia et al.
Diabetes Care 2009;32:1470-1472.
ABSTRACT
| FULL TEXT
Overweight, Obesity, and Pancreatic Cancer: Beyond Risk Alone
McWilliams and Petersen
JAMA 2009;301:2592-2593.
FULL TEXT
Diabetes in Asia: Epidemiology, Risk Factors, and Pathophysiology
Chan et al.
JAMA 2009;301:2129-2140.
ABSTRACT
| FULL TEXT
Long-term Mortality in Cancer Patients With Preexisting Diabetes
van de Poll-Franse and Coebergh
JAMA 2009;301:1541-1541.
FULL TEXT
|
